https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/new-technique-aid-diagnosis-glycosylation-disorders-present-birth/
New technique to aid diagnosis of glycosylation disorders present at birth
28 Jun 2016, 2:21 p.m.
A study, supported by the NIHR Great Ormond Street BRC, investigated the use of a 2D-differential gel electrophoresis (DIGE) method that provides a global analysis of the serum glycoproteome (glycomic profiling). 2D-DIGE allows multiple samples to be run simultaneously, eliminating gel-to-gel variations, and allowing direct overlay comparisons.
The results showed that for some CDG patients not all glycoproteins were consistently affected. The results identified several new and specific markers of N- and O-linked glycoproteins, never before described. These proteins were shown to be changed in patients, something that conventional tests failed to identify. The findings showed that 2D DIGE is an ideal method for investigation of the global glycoproteome and it could aid diagnosis and sub classification of complex CDG cases, with the potential to identify new diseases. This work was supported by the NIHR GOSH BRC and findings have been published in Molecular Genetics and Metabolism reports.
Congenital disorders of glycosylation (CDG) are a group of rare genetic, metabolic disorders caused by an error in glycosylation. There are over 60 different CDG identified, resulting in a broad range of clinical symptoms, making initial clinical assessment challenging. Screening of CDG is currently based on the investigation of the glycoproteins transferrin and apolipoprotein CIII. However, this cannot diagnose all potential defects in the glycosylation pathway and overlooks new inborn errors of metabolism, resulting in more subtle defects being missed.
Gene therapy offers potential to extend lives of children with rare immune disorder
Children have had their lives changed by a ground-breaking gene therapy treatment at Great Ormond Street Hospital for a rare immunodeficiency.
Cutting-edge genomic technology saves girl from rare brain infection
Great Ormond Street Hospital has launched the UK’s first accredited ‘metagenomics’ testing service, that allows clinicians to identify infections that are otherwise undetectable.
New research analyses key immune cell
A new study led by researchers at University College London Great Ormond Street Institute of Child Health has found that women have a higher proportion of key immune cells between puberty and menopause.
First patient treated with groundbreaking gene therapy trial
A baby boy born with a rare condition has become the first in the world to be treated with a new, potentially lifechanging, investigational gene therapy on a clinical trial at Great Ormond Street Hospital (GOSH).